Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection

• Main Authors: Annalisa Mondi (Author), Carmela Pinnetti (Author), Patrizia Lorenzini (Author), Maria Maddalena Plazzi (Author), Isabella Abbate (Author), Marta Camici (Author), Chiara Agrati (Author), Elisabetta Grilli (Author), Francesca Gili (Author), Rozenn Esvan (Author), Nicoletta Orchi (Author), Gabriella Rozera (Author), Alessandra Amendola (Author), Federica Forbici (Author), Caterina Gori (Author), Roberta Gagliardini (Author), Rita Bellagamba (Author), Adriana Ammassari (Author), Stefania Cicalini (Author), Maria Rosaria Capobianchi (Author), Andrea Antinori (Author)
• Format: Book
• Published: MDPI AG, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The optimal therapeutic approach for primary HIV infection (PHI) is still debated. We aimed to compare the viroimmunological response to a four- versus a three-drug regimen, both INSTI-based, in patients with PHI. This was a monocentric, prospective, observational study including all patients diagno...